Association between “D-dimeritis” in the emergency department and COVID-19 hospital burden

Authors

This study analyzed D-dimer tests requested by the two emergency departments of the University Hospital Trust of Verona during the Coronavirus disease 2019 (COVID-19) pandemic. Our findings show that the aggregate monthly number of D-dimer test requests from both emergency departments increased significantly (+39%) in 2021 compared to 2019, followed by a steady decline until 2024, when the aggregate monthly test requests were nearly threefold lower than before the pandemic. A strong association was observed between monthly D-dimer test requests and ICU admissions for COVID-19 in Verona (r=0.90; p=0.037), whereas no significant correlation was found with COVID-19 positive cases (r=0.11; p=0.855) or COVID-19 hospitalizations (r=0.70; p=0.118) in Verona. These results suggest that the heightened severity of COVID-19 cases during the early pandemic phase was a key driver of increased D-dimer test requests, while the subsequent decline may reflect reduced disease burden, improved test appropriateness through enhanced healthcare staff education, and a better understanding of COVID-19 pathophysiology.

Wauthier L, Favresse J, Hardy M, et al. D-dimer testing: A narrative review. Adv Clin Chem 2023;114:151-223.
Zhan H, Chen H, Liu C, et al. Diagnostic Value of D-Dimer in COVID-19: A Meta-Analysis and Meta-Regression. Clin Appl Thromb Hemost 2021;27:10760296211010976.
Lippi G, Mattiuzzi C, Favaloro EJ. Diagnostic value of D-dimer in differentiating multisystem inflammatory syndrome in Children (MIS-C) from Kawasaki disease: systematic literature review and meta-analysis. Diagnosis (Berl) 2024;11:231-4.
Conway EM, Mackman N, Warren RQ, et al. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol 2022;22:639-49.
Thachil J, Favaloro EJ, Lippi G. D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19. Semin Thromb Hemost 2022;48:672-9.
Favaloro EJ, Lay M, Mohammed S, et al. Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing. Pathology 2023;55:155-9.
Lippi G, Perilli V. Has "D-Dimeritis" Worsened during the Coronavirus Disease 2019 Pandemic? Semin Thromb Hemost 2023;49:565-7.
Mattiuzzi C, Lippi G. Timeline analysis of clinical severity of COVID-19 in the general population. Eur J Intern Med 2023;110:97-8.
Lippi G, Mullier F, Favaloro EJ. D-dimer: old dogmas, new (COVID-19) tricks. Clin Chem Lab Med 2022;61:841-50.
Onorato D, Negrini D, Lippi G. Laboratory medicine and COVID-19 pandemic impact effects of SARS-CoV-2 pandemic on laboratory medicine. Riv Ital Med Lab 2024;20:24-30.
Lippi G, Cervellin G, Casagranda I, et al. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med 2014;52:621-8.

How to Cite

Lippi, G., Ferrari, A., Maccagnani, A., & Paolillo, C. (2025). Association between “D-dimeritis” in the emergency department and COVID-19 hospital burden. Emergency Care Journal, 21(1). https://doi.org/10.4081/ecj.2025.13407

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.